These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 32726972)

  • 1. Efficacy and Mechanisms of Flavonoids against the Emerging Opportunistic Nontuberculous Mycobacteria.
    Mickymaray S; Alfaiz FA; Paramasivam A
    Antibiotics (Basel); 2020 Jul; 9(8):. PubMed ID: 32726972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimycobacterial strategies to evade antimicrobial resistance in the nontuberculous mycobacteria.
    Millar BC; Moore JE
    Int J Mycobacteriol; 2019; 8(1):7-21. PubMed ID: 30860173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diseases caused by nontuberculous mycobacteria in Asia.
    Lai CC; Hsueh PR
    Future Microbiol; 2014; 9(1):93-106. PubMed ID: 24328383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.
    Erber J; Weidlich S; Tschaikowsky T; Rothe K; Schmid RM; Schneider J; Spinner CD
    BMC Infect Dis; 2020 May; 20(1):365. PubMed ID: 32448204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin and Soft Tissue Infections Due to Nontuberculous Mycobacteria.
    Misch EA; Saddler C; Davis JM
    Curr Infect Dis Rep; 2018 Mar; 20(4):6. PubMed ID: 29556857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Extrapulmonary Nontuberculous Mycobacterial Diseases.
    Wi YM
    Infect Chemother; 2019 Sep; 51(3):245-255. PubMed ID: 31583858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medications and monitoring in nontuberculous mycobacteria infections.
    Egelund EF; Fennelly KP; Peloquin CA
    Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent.
    De Groote MA; Jarvis TC; Wong C; Graham J; Hoang T; Young CL; Ribble W; Day J; Li W; Jackson M; Gonzalez-Juarrero M; Sun X; Ochsner UA
    Front Microbiol; 2018; 9():2231. PubMed ID: 30294313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discontinuation of secondary prophylaxis in AIDS patients with disseminated non-tuberculous mycobacteria infection.
    Liao CH; Chen MY; Hsieh SM; Sheng WH; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2004 Feb; 37(1):50-6. PubMed ID: 15060688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nontuberculous Mycobacteria Lymphadenitis: A Case Report.
    Krantz AM; Varnam M; Fernandez C
    Cureus; 2016 Oct; 8(10):e846. PubMed ID: 27909634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimycobacterial Susceptibility Testing of Nontuberculous Mycobacteria.
    Brown-Elliott BA; Woods GL
    J Clin Microbiol; 2019 Oct; 57(10):. PubMed ID: 31315954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk factors for developing of chronic pulmonary aspergillosis in nontuberculous mycobacteria patients and clinical characteristics and outcomes in chronic pulmonary aspergillosis patients coinfected with nontuberculous mycobacteria.
    Takeda K; Imamura Y; Takazono T; Yoshida M; Ide S; Hirano K; Tashiro M; Saijo T; Kosai K; Morinaga Y; Nakamura S; Kurihara S; Tsukamoto M; Miyazaki T; Tashiro T; Kohno S; Yanagihara K; Izumikawa K
    Med Mycol; 2016 Feb; 54(2):120-7. PubMed ID: 26531100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.
    Tan Y; Su B; Shu W; Cai X; Kuang S; Kuang H; Liu J; Pang Y
    BMC Pulm Med; 2018 Nov; 18(1):168. PubMed ID: 30413193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontuberculous Mycobacterial Infections of the Lung.
    Kourbeti IS; Maslow MJ
    Curr Infect Dis Rep; 2000 Jun; 2(3):193-200. PubMed ID: 11095856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of human pulmonary infection with nontuberculous mycobacteria.
    Marras TK; Daley CL
    Clin Chest Med; 2002 Sep; 23(3):553-67. PubMed ID: 12370992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
    van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
    Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontuberculous Mycobacterial Infections in a French Hospital: A 12-Year Retrospective Study.
    Blanc P; Dutronc H; Peuchant O; Dauchy FA; Cazanave C; Neau D; Wirth G; Pellegrin JL; Morlat P; Mercié P; Tunon-de-Lara JM; Doutre MS; Pélissier P; Dupon M
    PLoS One; 2016; 11(12):e0168290. PubMed ID: 27959960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nontuberculous mycobacteria in patients with cystic fibrosis.
    Leung JM; Olivier KN
    Semin Respir Crit Care Med; 2013 Feb; 34(1):124-34. PubMed ID: 23460012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nontuberculous mycobacterial ocular and adnexal infections.
    Moorthy RS; Valluri S; Rao NA
    Surv Ophthalmol; 2012; 57(3):202-35. PubMed ID: 22516536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.